Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial.

Kenichi OgiwaraMasashi TakiTakashi SuzukiHideyuki TakedaniTadashi MatsushitaKagehiro AmanoMasanori MatsumotoKenji NishioMidori ShimaMasato KasaharaKeiji Nogami

Published in: BMJ open (2022)

jRCTs051190119.

Keyphrases

clinical trial
open label
study protocol
phase ii
double blind
phase iii
randomized controlled trial
radiation therapy
combination therapy
cross sectional